Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4366 to 4380 of 7691 results

  1. What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?

    Recommendation ID NG131/3 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate

    Research recommendation
    Published
    25 October 2019

  2. Primary care testing: Diagnostic accuracy studies of tests accessible to primary care should be carried out for a given cancer in symptomatic people. Priority areas for research should include tests for people with cough, non-visible haematuria, suspected prostate cancer, suspected pancreatic cancer, suspected cancer in childhood and young people and other suspected rare cancers. Outcomes of interest are the performance characteristics of the test, particularly sensitivity, specificity and positive and negative predictive values.

    Recommendation ID NG12/02 Question Primary care testing: Diagnostic accuracy studies of tests accessible to primary care should be carried

    Research recommendation
    Published
    7 January 2022

  3. Diagnostic investigations to predict treatment outcomes:- What is the prognostic value of the Hevylite assay and ratio compared with other prognostic factors and tests, including the serum-free light-chain assay and fluorescence in-situ hybridisation (FISH), in people with newly diagnosed myeloma who are starting treatment?

    Recommendation ID NG35/1 Question Diagnostic investigations to predict treatment outcomes:- What is the prognostic value of the Hevylite

    Research recommendation
    Published
    5 April 2016

  4. What is the effect of dietary interventions or dietary changes on acne?

    Recommendation ID NG198/3 Question What is the effect of dietary interventions or dietary changes on acne? Any explanatory notes(if

    Research recommendation
    Published
    3 May 2024

  5. Dietary supplements:- Should people with coeliac disease be offered calcium and vitamin D supplements for a specific time period soon after their initial diagnosis?

    Recommendation ID NG20/3 Question Dietary supplements:- Should people with coeliac disease be offered calcium and vitamin D supplements

    Research recommendation
    Published
    13 October 2015

  6. Dietitian contribution to patient management:- How can the role of the dietitian contribute most effectively within a coeliac disease team?

    Recommendation ID NG20/4 Question Dietitian contribution to patient management:- How can the role of the dietitian contribute most effectively

    Research recommendation
    Published
    13 October 2015

  7. What is the relative effectiveness and cost effectiveness of different oral fluids and different oral fluid regimens, both with and without oral N-acetylcysteine, at preventing contrast-induced acute kidney injury?

    Recommendation ID NG148/2 Question What is the relative effectiveness and cost effectiveness of different oral fluids and different oral

    Research recommendation
    Published
    10 February 2020

  8. What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of supported digital cognitive–behavioural therapy (CBT) compared with unsupported digital CBT in young people aged 12 to 18 years with mild depression, and what are the key components of the interventions that influence effectiveness?

    Recommendation ID NG134/2 Question What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of supported

    Research recommendation
    Published
    25 October 2019

  9. What is the effectiveness of diuretics compared with placebo in preventing bronchopulmonary dysplasia (BPD) in preterm babies on respiratory support?

    Recommendation ID NG124/3 Question What is the effectiveness of diuretics compared with placebo in preventing bronchopulmonary dysplasia

    Research recommendation
    Published
    16 August 2019

  10. When is it safe to stop contact casting in the treatment of acute Charcot arthropathy?

    Recommendation ID NG19/12 Question When is it safe to stop contact casting in the treatment of acute Charcot arthropathy? Any explanatory

    Research recommendation
    Published
    18 November 2019

  11. Which risk stratification tools can be used to predict the likelihood of Charcot arthropathy?

    Recommendation ID NG19/11 Question Which risk stratification tools can be used to predict the likelihood of Charcot arthropathy?

    Research recommendation
    Published
    18 November 2019

  12. Chemical sympathectomy for managing critical limb ischaemic pain:- What is the clinical and cost effectiveness of chemical sympathectomy in comparison with other methods of pain control for managing critical limb ischaemic pain?

    Recommendation ID CG147/5 Question Chemical sympathectomy for managing critical limb ischaemic pain:- What is the clinical and cost effectiveness

    Research recommendation
    Published
    9 June 2015

  13. What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment for adults with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics?

    Recommendation ID NG144/6 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

    Research recommendation
    Published
    10 February 2020

  14. Chemoprevention to reduce incidence of breast cancer:- A randomised controlled trial is recommended to compare the clinical and cost effectiveness of aromatase inhibitors and tamoxifen for reducing the incidence of breast cancer in women with a family history of breast or ovarian cancer. [new 2013]

    Recommendation ID CG164/4 Question Chemoprevention to reduce incidence of breast cancer:- A randomised controlled trial is recommended

    Research recommendation
    Published
    9 June 2015

  15. What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment in babies, children and young people with chemotherapy-induced nausea or vomiting which persists with optimised conventional antiemetics?

    Recommendation ID NG144/7 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

    Research recommendation
    Published
    10 February 2020